Rigshospitalet ( Site 4467)

Copenhagen, Capital Region DK-2100

1 studies enrolling now · 1 studies all time

What they study most

Malignant Neoplasm

Studies at this site

• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) — Recruiting now